Drug alerts › Bajaj Formulations Khasra No. 161
Bajaj Formulations Khasra No. 161: drug alert entries
Batches made by Bajaj Formulations Khasra No. 161 (as named by CDSCO) that appear in CDSCO drug alerts: 5 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Aceclofenac and Paracetamol Tablets (DICLORISE-AP Tablets)NSQ
Result: TESTS FOR UNIFORMITY OF WEIGHT.
Diclofenac Potassium, & Serratiopeptidase Tablets (Puldase - D)NSQ
Result: The sample is not of Standard Quality with respect to Disintegration
Aceclofenac and Parcetamol IP) (Valuegesic Tablets)NSQ
Result: 01. ASSAY OF ACECLOFENAC I.P. –Less than prescribed limit.
Diabit-GMNSQ
Result: The sample fails in the Test for Description
Intraconazole Capsules 100 mg (ITRASEC-100)NSQ
Result: The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.